NEW YORK (Reuters Health) – A new study has a bit of good news for most women who've had breast cancer surgery.
It turns out that sticking with the older and relatively cheap drug tamoxifen for the recommended 5 years instead of just 2 will cut the risk of having the cancer return.
And there is an added bonus: For women in their 50s, the longer drug treatment also reduced the chance they'd develop heart disease.
"That little
No comments:
Post a Comment